Send PM
Followers 9
Posts 602
Boards Moderated 0
Alias Born 02/08/2013

Re: None

Wednesday, 06/26/2013 8:26:18 AM

Wednesday, June 26, 2013 8:26:18 AM

Post# of 33
The stock is now down by more than 11% from its highs. This is the trend with most pharmaceutical stocks as the corrective mood in the market has added to the pressure from profit booking. The weakness in Covidien is highlighted by the fact that it is trading below crucial levels and bounces have not sustained so far. Over the years, the stock has done great for the investors with good appreciation from the lows of around $28 made in 2009. The returns have been good during the past one year also, and stock is still up by 16% on a 52 week basis. The correction has reduced the pressure on valuations and now it is trading around 16 times ttm earnings. Over the years the growth has been more uniform and the revenue and net income have grown. However, there has been some tapering off recently. In the last quarter, the sales had grown by about 5%, but the net income had fallen by about 12%. Future success depends on its ability to deliver new devices / drugs from time to time. Medical devices comprise 68% of its sales and hence it is imperative to bring innovative products to support growth in revenues. Even smaller medical device companies are bringing out interesting products like RenalGuard from PLC Systems (PLCSF) which has got several patents from US / Europe. Covidien recently announced good progress in trials of some of its products. Its Kendall SCD system with Vascular Refill Detection Technology was found to be effective in decreasing development of proximal deep vein thrombosis (DVT). Analysts remain positive on the stock with Goldman Sachs (GS) expecting acceleration in sales and earnings from the second half of FY14. The analysts have a consensus buy recommendation on Covidien with the average price target of around $72 (17-18% appreciation).

Day Range:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Recent COV News

ILUS Confirms Share Lock-Up Opportunity ILUS Sep 29, 2022 1:25 PM

ILUS Appoints Investment Bank to Assist With Up-List and Associated Acquisitions ILUS Sep 29, 2022 11:22 AM

New Break Identifies High-Grade Gold, up to 70.60 g/t Au, via Grab Sampling at Moray NBRK Sep 29, 2022 10:29 AM

Arts & Collectibles DOT Company Coinllectibles Seeing a Very Bright Future with Revenue jumping by 100% to US$8.8 Million in First Half of 2022 as compared to The Year Before COSG Sep 29, 2022 8:44 AM

Rising Star Trillion Energy Ready to Supply Much Needed European Gas TCF Sep 29, 2022 8:00 AM

GBT is researching the Development of Electro-Thermal Aware Design Environment for Integrated Circuits.Seeking to Address Advanced Nanometer Nodes Semiconductors Electro-Thermal Modeling and Optimization. GTCH Sep 29, 2022 7:30 AM

Goldshore Intersects 192.75m @ 1.02 g/t Au from 94.45m depth in MMD-22-051 GSHRF Sep 29, 2022 7:30 AM

SFLMaven Plans for New Potential Revenue from Patent Pending HolgoGlow Technology for the Metaverse SFLM Sep 29, 2022 6:30 AM

Ludwig's genomic-based mRNA Inflammatory Index - a Ground-Breaking Technology LUDG Sep 28, 2022 1:34 PM

Headwater Gold Commences Multi-Rig Drill Program at the Spring Peak Project, Nevada to Follow Up Epithermal Vein Discoveries HWAUF Sep 28, 2022 10:13 AM

Valiant Eagle Inc. (OTC: PSRU) Significantly Increases Its Equity Stake in Sumer Technologies, Inc., as the Ride-Sharing Company Readies Its Much Anticipated Innovative Zumr App For Q1 2023 U.S. Launch PSRU Sep 28, 2022 9:30 AM

Good Gaming Inc. Announces Official Launch Date For Their New Minecraft OP Prison Game Featuring MicroBuddiesTM GMER Sep 28, 2022 9:15 AM

Trend Innovations Holding Inc. Completes the Second Version of the AI Consultant Chatbot on the Company's Website TREN Sep 28, 2022 9:00 AM

GBT will be attending the Interactive MoneyShow Virtual Expo, on Sep 27-29, Presenting its Technologies, Innovations and Future Visions GTCH Sep 28, 2022 7:30 AM

Branded Legacy, Inc. Reduces Authorized Shares By 300 Million BLEG Sep 27, 2022 11:53 AM